CoQ10 supplementation during pregnancy has not been linked to harmful effects in the clinical trials conducted so far, and at least one randomized trial found it cut preeclampsia risk roughly in half among women already at elevated risk. But the evidence base remains thin: only a handful of human studies have tested CoQ10 specifically in pregnant women, and no major obstetric guideline currently includes it as a standard recommendation. That gap between promising early data and formal endorsement is the reality anyone considering CoQ10 during pregnancy has to navigate.
What CoQ10 Does in a Normal Pregnancy
Your body already makes CoQ10, and pregnancy appears to dial up production. Plasma CoQ10 levels rise steadily across all three trimesters, tracking alongside cholesterol and other lipid markers that also climb during pregnancy.1PubMed. Positive correlation between maternal serum coenzyme Q10 levels and infant birth weight This makes biological sense: CoQ10 sits inside mitochondria, where it helps generate energy for cells and neutralizes damaging byproducts of that energy production. A growing placenta and fetus demand enormous amounts of cellular energy, so the body ramps up its supply.
Earlier research found that when CoQ10 levels fail to rise as expected, the pregnancy is more likely to end in miscarriage. Women who spontaneously aborted had plasma CoQ10 levels that stayed flat rather than climbing along the normal trimester curve.2PubMed. Coenzyme Q10 in pregnancy That does not prove low CoQ10 caused the loss; it may simply be a marker of a placenta that was already failing. But it does suggest that adequate CoQ10 levels track with healthier pregnancies.
The Preeclampsia Trial
The strongest human evidence for CoQ10 supplementation in pregnancy comes from a randomized, double-blind, placebo-controlled trial of women considered at increased risk for preeclampsia. Women received either 200 mg of CoQ10 or a placebo daily starting at 20 weeks of gestation and continuing until delivery. In the placebo group, about one in four women developed preeclampsia, compared with about one in seven in the CoQ10 group. That translated to a relative risk of 0.56, meaning the supplement roughly halved the odds of developing the condition.3PubMed. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia
Those numbers are encouraging, but context matters. This was a single trial, not a body of replicated evidence. Preeclampsia is a complex condition driven by abnormal placental development, blood vessel dysfunction, and immune factors, and many interventions that looked promising in a single trial have not held up in larger follow-ups. The trial also started supplementation at 20 weeks, well into the second trimester, so it cannot speak to whether earlier supplementation would be more or less effective. Researchers studying CoQ10 in a rodent model of preeclampsia did find that it lowered blood pressure, reduced protein in the urine, and improved placental mitochondrial function while restoring birth weight in pups, which at least supports a plausible mechanism.4PubMed Central. A role for the antioxidants coenzyme Q10 and pyrroloquinoline quinone in mitigating obesity-associated reproductive dysfunction – Section: CoQ10 attenuates the risk of complications in pregnancy
Still, one well-designed trial and some animal data do not amount to a guideline-level recommendation. If you have risk factors for preeclampsia and are considering CoQ10, that conversation belongs with your obstetrician, who can weigh the modest evidence against your individual situation.
CoQ10 and the Placenta
One question that comes up is whether supplemental CoQ10 actually reaches the placenta and the baby. Research on this gives a mixed picture. When women in a trial took CoQ10, their placental tissue at delivery showed different patterns depending on whether the pregnancy was healthy or complicated. Among women who developed preeclampsia, those receiving CoQ10 had significantly higher CoQ10 levels in their placental tissue compared to women with normal pregnancies in the same supplement group. However, when researchers looked specifically at mitochondrial CoQ10 within the placenta, there was no difference between the supplemented and placebo groups among women with preeclampsia.5Free Radical Biology and Medicine. Placental and mitochondrial Q10 content after CoQ10 supplementation during pregnancy
That distinction matters. It suggests that supplemental CoQ10 does reach the placenta in measurable amounts, but it may accumulate in cell membranes rather than being efficiently channeled into the mitochondria where it is most needed for energy production. The placenta is not a simple pass-through; it actively regulates what reaches the fetus, and CoQ10’s behavior there appears to be more complicated than “take more, get more where it counts.”
Separate work measuring CoQ10 in amniotic fluid found that plasma levels during pregnancy were much higher than amniotic levels, which suggests limited transfer across the placental barrier into the fetal compartment. In pregnancies complicated by fetal growth restriction, amniotic CoQ10 was actually elevated compared to healthy pregnancies, while antioxidant capacity in the same fluid was lower.6PubMed Central. Amniotic coenzyme Q10: is it related to pregnancy outcomes? Higher amniotic CoQ10 paired with lower antioxidant protection seems paradoxical, and the researchers proposed it could reflect a stressed placenta releasing CoQ10 rather than utilizing it effectively. Amniotic CoQ10 also correlated negatively with birth weight, meaning higher levels were associated with smaller babies. Again, this is more likely a marker of trouble than a cause of it, but it underscores that the relationship between CoQ10 and fetal outcomes is not straightforwardly “more is better.”
Before Pregnancy: CoQ10 and Fertility
Much of the buzz around CoQ10 and reproduction centers on its use before conception, particularly for women undergoing assisted reproduction. Egg cells are among the most mitochondria-dense cells in the body, and the energy demands of maturation, fertilization, and early embryonic division are extraordinary. As women age, mitochondrial function in eggs declines, and this is thought to be one driver of reduced fertility and higher rates of chromosomal abnormalities in embryos.
CoQ10 supplementation has been studied as a way to support mitochondrial function in eggs, and a recent review of the evidence concluded that it reduces reactive oxygen species, improves oocyte quality, and optimizes outcomes during fertility treatments.7PubMed Central. Exploring the protective effects of coenzyme Q10 on female fertility The rationale is straightforward: CoQ10 helps mitochondria produce energy more efficiently while simultaneously mopping up the damaging byproducts, and eggs need both of those functions operating at peak performance.8PubMed Central. Does Coenzyme Q10 Supplementation Improve Human Oocyte Quality?
Most fertility-focused CoQ10 use happens in the months leading up to conception or an IVF cycle, not during pregnancy itself. The practical overlap arises because women taking CoQ10 for fertility may become pregnant and wonder whether to continue. Nothing in the current literature suggests a reason to abruptly stop CoQ10 upon getting a positive pregnancy test, but the rationale for continuing shifts from egg quality (no longer relevant once conception has occurred) to the pregnancy-related benefits discussed above, which are less well established for the first trimester specifically.
Gestational Diabetes and CoQ10 Levels
Gestational diabetes is another pregnancy complication where CoQ10 has drawn interest, though the evidence here is observational rather than interventional. Researchers measured plasma CoQ10 in women with gestational diabetes and compared them to controls across different stages of pregnancy. When CoQ10 was adjusted for cholesterol (since both rise in pregnancy and CoQ10 travels on cholesterol-carrying particles), there was no meaningful difference between the groups for most of pregnancy. But in late pregnancy, between 36 and 40 weeks, women with gestational diabetes had significantly higher CoQ10-to-cholesterol ratios alongside markers of increased insulin resistance and oxidative stress.9Elsevier / PubMed Central. Plasma coenzyme Q10 is increased during gestational diabetes
This pattern mirrors what was seen in amniotic fluid during fetal growth restriction: elevated CoQ10 appeared alongside worsening metabolic markers, suggesting the body might be cranking out more CoQ10 in response to oxidative stress rather than the other way around. No interventional trial has yet tested whether giving CoQ10 supplements to women with gestational diabetes improves blood sugar control or pregnancy outcomes. Until that work is done, the connection between CoQ10 and gestational diabetes stays in the “interesting observation” category rather than “actionable supplement advice.”
What Happens After Delivery
If you have been taking CoQ10 during pregnancy, you might wonder whether it continues into breast milk. It does. Colostrum, the thick early milk produced in the first days after birth, is a particularly rich source of CoQ10. Levels then decline steadily as mature milk comes in. In one study, CoQ10 in milk dropped significantly from colostrum through transitional to mature milk, and the early-milk CoQ10 levels correlated with the mother’s own plasma CoQ10.10PubMed. Coenzyme Q10 in maternal plasma and milk throughout early lactation
This makes sense from a newborn-nutrition perspective. A baby’s antioxidant defenses are immature at birth, and colostrum delivers a concentrated package of protective compounds during the vulnerable first days. Whether supplementing with CoQ10 during late pregnancy or early postpartum meaningfully increases the CoQ10 content of breast milk has not been specifically tested, but the correlation between maternal plasma and early milk levels suggests it could.
Ubiquinol Versus Ubiquinone
CoQ10 supplements come in two forms. Ubiquinone is the oxidized form and has been around longer. Ubiquinol is the reduced, active form that your body converts ubiquinone into before using it. Both are sold widely, but they are not absorbed equally well. A crossover study in healthy adults found that ubiquinol delivered roughly double the peak blood levels and double the overall exposure compared to the same dose of ubiquinone.11PubMed Central. A Randomized, Double-Blind, Two-Treatment, Two-Period, Crossover Study Investigating the Systemic Bioavailability of a Novel Cocrystal Ubiquinol Formulation Compared with a Ubiquinone Formulation in Healthy Adults Other research confirms that ubiquinol has meaningfully higher bioavailability and potentially better therapeutic effect.12PubMed Central. The Cocrystal of Ubiquinol: Improved Stability and Bioavailability
For a pregnant woman, higher absorption per milligram could mean a lower effective dose is needed, which is a practical advantage. However, the preeclampsia trial that produced the positive results used ubiquinone at 200 mg per day, so that is the form and dose with the most direct pregnancy-specific evidence behind it. If you choose ubiquinol, there is no equivalent pregnancy trial telling you exactly what dose to use, though the pharmacokinetic data suggest a lower dose could achieve similar blood levels. This is one of those areas where the science is ahead of the supplement labels but behind the clinical guidelines.
What the Formal Guidelines Say
Here is where the picture gets frustrating for someone looking for clear direction: no major obstetric organization, including ACOG in the United States or NICE in the United Kingdom, currently recommends CoQ10 supplementation during pregnancy. This is not because the evidence is negative. It is because the evidence is insufficient for a guideline-level recommendation. One positive randomized trial and a collection of observational and mechanistic studies do not clear the bar that guideline committees use, which typically requires multiple large, well-powered trials with consistent results.
CoQ10 is classified as a dietary supplement, not a pharmaceutical, which means it does not go through the same premarket safety review that drugs do. No supplement undergoes formal FDA approval for use in pregnancy. The practical result is that your obstetrician may be comfortable with you taking it, cautiously supportive based on the preeclampsia data, or unfamiliar with the literature entirely. The evidence does not suggest harm, but absence of evidence of harm is not the same as evidence of safety, and that distinction weighs heavily when the stakes involve a developing pregnancy.
Doses in the published pregnancy research have ranged from 100 to 200 mg per day, typically started in the second trimester. No trial has tested first-trimester supplementation in humans, so the safety profile in early pregnancy specifically is inferred from general CoQ10 safety data in non-pregnant adults rather than demonstrated directly. Side effects in the trials that have been conducted were mild and did not differ meaningfully from placebo.
The Quality Problem with Supplements
Because CoQ10 is sold as a dietary supplement, the product you buy is not guaranteed to contain what the label claims. Supplements in the United States are not subject to premarket testing for potency, purity, or accuracy of labeling. Some brands voluntarily submit to third-party testing by organizations such as USP, NSF International, or ConsumerLab, and those verified products carry a seal on the label. During pregnancy, when you want to minimize exposure to contaminants and know exactly what you are taking, choosing a third-party verified product is more than a nice-to-have; it is the minimum responsible step.
CoQ10 is fat-soluble, so absorption improves when taken with a meal that contains some fat. Splitting a 200 mg dose into two 100 mg doses taken with meals may improve absorption compared to taking it all at once, though this has not been tested specifically in pregnant women. Timing relative to other prenatal supplements does not appear to matter, and no known interactions with standard prenatal vitamins have been reported.
When CoQ10 During Pregnancy Might Not Be Appropriate
CoQ10 can interact with blood-thinning medications like warfarin by potentially reducing their effectiveness. If you are on anticoagulant therapy during pregnancy, which some women are for conditions like antiphospholipid syndrome or a history of blood clots, adding CoQ10 without medical supervision could be risky. CoQ10 may also modestly lower blood pressure, which is usually welcome in preeclampsia-prone women but could be a concern if your blood pressure is already running low or if you are on antihypertensive medication where the combined effect could cause dizziness or fainting.
Women with thyroid conditions should also be aware that some research suggests CoQ10 may influence thyroid hormone levels, though this has not been studied specifically in pregnancy. And because CoQ10 has not been tested in the first trimester, women in the earliest weeks of pregnancy lack direct safety data for that period. The general toxicology profile of CoQ10 is reassuring even at high doses in non-pregnant populations, but the first trimester involves the most sensitive period of organ formation, and caution is reasonable when direct data is absent.
Maternal Birth Weight Connection
One intriguing finding from observational research is a positive correlation between maternal CoQ10 levels and infant birth weight. Women with higher serum CoQ10 in their third trimester tended to deliver heavier babies.1PubMed. Positive correlation between maternal serum coenzyme Q10 levels and infant birth weight This sits in interesting tension with the amniotic fluid finding, where higher amniotic CoQ10 was associated with lower birth weight in growth-restricted pregnancies.6PubMed Central. Amniotic coenzyme Q10: is it related to pregnancy outcomes? The likely explanation is that maternal blood levels and amniotic levels are measuring different things. Higher maternal blood CoQ10 probably reflects a well-functioning metabolism and adequate nutrition, both of which support fetal growth. Higher amniotic CoQ10 in a growth-restricted pregnancy probably reflects placental distress and leakage of CoQ10 into a compartment where it is not being used productively. The lesson is that CoQ10 is not a single number with a single meaning; where it is and why it is elevated matters enormously.